Schäfer, R., & Schlander, M. (2018). Is the National Institute for Health and Care Excellence (NICE) in England more ‘innovation-friendly’ than the Federal Joint Committee (G-BA) in Germany? Expert review of pharmacoeconomics and outcomes research, 19(4), . https://doi.org/10.1080/14737167.2019.1559732
Chicago-Zitierstil (17. Ausg.)Schäfer, Ramon, und Michael Schlander. "Is the National Institute for Health and Care Excellence (NICE) in England More ‘innovation-friendly’ than the Federal Joint Committee (G-BA) in Germany?" Expert Review of Pharmacoeconomics and Outcomes Research 19, no. 4 (2018). https://doi.org/10.1080/14737167.2019.1559732.
MLA-Zitierstil (9. Ausg.)Schäfer, Ramon, und Michael Schlander. "Is the National Institute for Health and Care Excellence (NICE) in England More ‘innovation-friendly’ than the Federal Joint Committee (G-BA) in Germany?" Expert Review of Pharmacoeconomics and Outcomes Research, vol. 19, no. 4, 2018, https://doi.org/10.1080/14737167.2019.1559732.